DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mozobil (Plerixafor Subcutaneous) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Death (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mozobil (Plerixafor Subcutaneous) where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Mozobil side effects in female

Reported by a physician from United States on 2012-06-01

Patient: female, weighing 73.8 kg (162.4 pounds)

Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-16
    End date: 2011-01-16

Bortezomib
    Dosage: 1.3 mg/m2, once
    Indication: Multiple Myeloma
    Start date: 2011-01-06
    End date: 2011-01-06

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-02-06
    End date: 2011-02-06

Mozobil
    Dosage: 320 mcg/kg, once
    Indication: Multiple Myeloma
    Start date: 2011-01-09
    End date: 2011-01-09

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-09
    End date: 2011-01-09

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-04
    End date: 2011-01-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-16
    End date: 2011-01-16

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-02-06
    End date: 2011-02-06

Other drugs received by patient: Advair Diskus 100 / 50; Norvasc; Albuterol; Zithromax



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-05-11

Patient: female, weighing 73.8 kg (162.4 pounds)

Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-02-06
    End date: 2011-02-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Indication: Multiple Myeloma
    Start date: 2011-01-06
    End date: 2011-01-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-02-06
    End date: 2011-02-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-04
    End date: 2011-01-06

Mozobil
    Dosage: 320 mcg/kg, once
    Indication: Multiple Myeloma
    Start date: 2011-01-09
    End date: 2011-01-09

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-16
    End date: 2011-01-16

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-16
    End date: 2011-01-16

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-13
    End date: 2011-01-13

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-09
    End date: 2011-01-09

Other drugs received by patient: Albuterol; Norvasc; Zithromax; Advair Diskus 100 / 50



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-04-26

Patient: female, weighing 52.6 kg (115.7 pounds)

Reactions: Death, Systemic Mycosis, Adenovirus Infection, Osteomyelitis, Bone Marrow Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Cefepime; Hydrocortisone; Lorazepam; Ranitidine; Etoposide; Dapsone; Pantoprazole; Acetaminophen; Cytarabine; Enalapril Maleate; Diphenhydramine HCL; Hydroxyzine; Nifedipine; Ondansetron; Vancomycin



Possible Mozobil side effects in

Reported by a consumer/non-health professional from Germany on 2012-04-24

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Mozobil
    Indication: Multiple Myeloma

Mozobil
    Dosage: unk
    Indication: Haematopoietic Stem Cell Mobilisation



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-04-19

Patient: female, weighing 73.8 kg (162.4 pounds)

Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-02-06
    End date: 2011-02-06

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-16
    End date: 2011-01-16

Bortezomib
    Dosage: 1.3 mg/m2, once
    Indication: Multiple Myeloma
    Start date: 2011-01-06
    End date: 2011-01-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-16
    End date: 2011-01-16

Mozobil
    Dosage: 320 mcg/kg, once
    Indication: Multiple Myeloma
    Start date: 2011-01-09
    End date: 2011-01-09

Mozobil
    Dosage: 320 mcg/kg, once
    Start date: 2011-01-13
    End date: 2011-01-13

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-13
    End date: 2011-01-13

Mozobil
    Dosage: 320 mcg/kg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-04
    End date: 2011-01-06

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-01-09
    End date: 2011-01-09

Bortezomib
    Dosage: 1.3 mg/m2, once
    Start date: 2011-02-06
    End date: 2011-02-06

Other drugs received by patient: Albuterol; Norvasc; Advair Diskus 100 / 50; Zithromax



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-17

Patient: female, weighing 91.4 kg (201.1 pounds)

Reactions: Fluid Overload, Death, Lymphopenia, Opportunistic Infection, Febrile Neutropenia, Convulsion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: 240 mcg/kg, qd
    Start date: 2011-12-05
    End date: 2011-12-05

Mozobil
    Dosage: 240 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-23
    End date: 2011-11-23

Other drugs received by patient: Neupogen; Phenergan HCL; Fexofenadine W; Sodium Chloride; Sorafenib; ABH; Dilaudid; Lomotil; Zofran; Valtrex; Hydralazine HCL; Hydromorphone HCL; Sodium Chloride; Sodium Chloride; Neupogen; Cytarabine; Protonix; Toprol-XL; Triamcinolone; Dextromethorphan W; Ondansetron; Oyster Shell Calcium; Silver Sulfadiazine; Sodium Chloride; Albuterol; Ambien; Phenergan HCL; Zofran; Diovan HCT; Heparin Lock-Flush; Synthroid; Triamcinolone; Camphor W; Magnesium Sulfate; Potassium Chloride; Docusate Sodium W; Tramadol HCL; White Petroleum; Hycodan; Protonix; Vantin; Fluocinonide; Hydrocodone W; Hydromorphone HCL; Insulin Lispro; Linezolid; ABH; Acetaminophen; Cefepime Hydrochloride; Diphenhydramine HCL; Granisetron; Throat Preparations; Potassium Chloride; Xanax; Diovan HCT; Lantus; Magnesium; Potassium; Dextrose; Hydroxyzine; Insulin Lispro; Ondansetron; Docusate Sodium W; Vitamin TAB; Sucralfate; Tramadol HCL; Sorafenib; Tessalon; Effexor XR; Novolog; Vfend; Acetaminophen; Aluminium W; Cefepime Hydrochloride; Hydrocodone W; Hydrocortisone Sodium Succinate; Hydromorphone HCL; Magnesium Sulfate; Metoclopramide; Sodium Chloride



Possible Mozobil side effects in 74 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-09

Patient: 74 year old female, weighing 67.6 kg (148.7 pounds)

Reactions: Hypotension, Generalised Oedema, Splenic Infarction, Ascites, Death, Dehydration, Splenic Haemorrhage, Vascular Pseudoaneurysm, Splenomegaly, Splenic Rupture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: 22840 mcg, qd
    Start date: 2012-01-31
    End date: 2012-02-01

Mozobil
    Dosage: 22840 mcg, qd
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-30
    End date: 2012-01-30

Mozobil
    Dosage: 13704 mcg, once
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2012-01-25
    End date: 2012-01-25

Filgrastim
    Dosage: 570 mcg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2012-01-25
    End date: 2012-02-01

Other drugs received by patient: Miralax; Steroid Therapy; Vitamin D; Oxycodone HCL; Oxycodone HCL; Fluorodeoxyglucose F 18; Calcium; Colace



Possible Mozobil side effects in

Reported by a consumer/non-health professional from United States on 2011-12-14

Patient:

Reactions: Death, Restlessness, Nausea, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Cytarabine; Etoposide; Neupogen; Mitoxantrone



Possible Mozobil side effects in

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2011-10-31

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Neupogen



Possible Mozobil side effects in

Reported by a physician from Netherlands on 2011-10-19

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Neupogen



Possible Mozobil side effects in

Reported by a physician from Netherlands on 2011-10-04

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Neupogen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017